Watson Pharma launched the generic version of
Pfizer's blockbuster cholesterol-busting drug Lipitor, dubbing it the
"largest generic product launch in US history".
Under the terms of the exclusive supply and distribution agreement, Pfizer manufactures and supplies Watson with all dosage strengths of the authorised generic product.
Watson markets and distributes the product in the US," the firm said. Watson has not revealed it’s pricing for the drug, but analysts said it will have to sell the drug at a competitive price. Pfizer has been selling the drug for as low as $4 for 30 days.
Watson's launch raises questions on Ranbaxy Laboratories' revenues from the drug. India's third-largest drug company was scheduled to launch the generic version of the drug on Wednesday, but is struggling to get approvals from the US drug regulator.
Under the terms of the exclusive supply and distribution agreement, Pfizer manufactures and supplies Watson with all dosage strengths of the authorised generic product.
Watson markets and distributes the product in the US," the firm said. Watson has not revealed it’s pricing for the drug, but analysts said it will have to sell the drug at a competitive price. Pfizer has been selling the drug for as low as $4 for 30 days.
Watson's launch raises questions on Ranbaxy Laboratories' revenues from the drug. India's third-largest drug company was scheduled to launch the generic version of the drug on Wednesday, but is struggling to get approvals from the US drug regulator.
No comments:
Post a Comment